Global BCG Vaccine Market (2020 to 2024) - Insights & Forecast with Potential Impact of COVID-19 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

The global BCG vaccine market is anticipated to reach US$65.53 million in 2024, growing at a CAGR of 4.70% during the period spanning 2020-2024.

Growth in the global BCG vaccine market was driven by factors like increasing prevalence of tuberculosis, rising R&D funding on tuberculosis, growing incidences of bladder cancer, increasing prevalence of extensively drug resistant tuberculosis and surging BCG immunization coverage. The key trends that are expected to be faced by the market are declining targeted incidence rate of tuberculosis and decreasing targeted mortality of tuberculosis. The limited impact of BCG vaccine on adults is expected to impose a challenge on the global BCG vaccine market.

The global BCG vaccine market by drug type can be segmented as follows: immune BCG and therapy BCG. In 2019, the higher share of the market was held by immune BCG. The global BCG vaccine by end user can be segmented into the following pediatrics and adults. The dominant share of the market in 2019 was held by pediatrics. The market by usage can be divided into the following segments: tuberculosis and bladder cancer. The largest share of the market was obtained by tuberculosis in 2019. The global BCG vaccine market by application can be segmented as follows: hospitals and clinics, with hospitals holding a greater share of the market in 2019.

Companies Mentioned

• Merck & Co.
• China National Biotec Group (CNBG)
• Green Signal Bio Pharma Ltd
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Statens Serum Institut
  

Scope of the report:

• The report provides a comprehensive analysis of the global BCG vaccine market with potential impact of COVID-19.
• The major regional markets (North America, Europe and Asia Pacific) have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Merck & Co., Sanofi, Statens Serum Institut, China National Biotec Group (CNBG), Serum Institute of India Pvt. Ltd., Green Signal Bio Pharma Ltd) are also presented in detail.
  

Key Topics Covered:

1. Market Overview

2. Impact of COVID-19

2.1 Impact on Global Economy

2.2 Change in Organic Traffic

2.3 Global Prevalence of COVID-19

3. Market Analysis

3.1 Global BCG Vaccine Market by Value

3.2 Global BCG Vaccine Market Forecast by Value

3.3 Global BCG Vaccine Market by Drug Type

3.3.1 Global Immune BCG Market by Value

3.3.2 Global Immune BCG Market Forecast by Value

3.3.3 Global Therapy BCG Market by Value

3.3.4 Global Therapy BCG Market Forecast by Value

3.4 Global BCG Vaccine Market by End User

3.4.1 Global Pediatric BCG Vaccine Market by Value

3.4.2 Global Pediatric BCG Vaccine Market Forecast by Value

3.4.3 Global Adult BCG Vaccine Market by Value

3.4.4 Global Adult BCG Vaccine Market Forecast by Value

3.5 Global BCG Vaccine Market by Usage

3.5.1 Global Tuberculosis BCG Vaccine Market by Value

3.5.2 Global Tuberculosis BCG Vaccine Market Forecast by Value

3.5.3 Global Bladder Cancer BCG Vaccine Market by Value

3.5.4 Global Bladder Cancer BCG Vaccine Market Forecast by Value

3.6 Global BCG Vaccine Market by Application

3.6.1 Global Hospital BCG Vaccine Market Forecast by Value

3.6.2 Global Clinic BCG Vaccine Market Forecast by Value

3.7 Global BCG Vaccine Market by Region

4. Regional Market

4.1 North America

4.2 Europe

4.3 Asia Pacific

4.4 ROW

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Surging Prevalence of Tuberculosis

5.1.2 Increasing Research & Development Funding on Tuberculosis

5.1.3 Rising Incidence of Bladder Cancer

5.1.4 Upsurge in the US Funding for Tuberculosis

5.1.5 Rising Prevalence of Extensively Drug-Resistant Tuberculosis

5.1.6 Increasing BCG Immunization Coverage

5.2 Key Trends & Developments

5.2.1 Declining Targeted Incidence Rate of Tuberculosis

5.2.2 Decreasing Targeted Mortality of Tuberculosis

5.3 Challenges

5.3.1 Limited Impact of BCG on Adults

6. Competitive Landscape

6.1 Global Market

6.1.1 Revenue Comparison- Key Players

6.1.2 Market Capitalization Comparison- Key Players

6.1.3 Research & Development Expenses Comparison - Key Players

6.1.4 Global BCG Market Share Comparison - Key Players

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/4syjw8